21
Participants
Start Date
March 31, 2004
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2008
Single arm (ganciclovir and valganciclovir)
Patients received a short induction of IV ganciclovir at 5 mg/kg bid for 5 days (1 hour infusion) , followed by treatment with oral valganciclovir at 900 mg bid (after meals) for 16 days up to complet 21 days of treatment. In patients with impaired renal function, IV ganciclovir and oral valganciclovir doses were adjusted at each visit according to estimated GFR (Cockroft-Gault equation)
Hospital Universitari Bellvitge- Transplant Departments (Liver, Heart and Kidney), L'Hospitalet de Llobregat
Roche Pharma AG
INDUSTRY
Salvador Gil-Vernet
OTHER